Podoplanin is widely expressed in the brain, lung, heart, kidney, bone, and lymphoid organs (143), and high expression of podoplanin is associated with an increased risk of venous thromboembolism in tumor patients (144). This evidence concerns the gene PDPN and venous thromboembolism.